hengrui glp-1 HRS-7535, an oral small-molecule receptor agonist, in Chinese adults with obesity without diabetes: a randomized, double-blind, placebo-controlled phase 2 trial Ends 02/14/2016! 💘 treat Size:1 Cookie innofit30-text

hengrui glp-1 HRS-7535, an oral small-molecule receptor agonist, in Chinese adults with obesity without diabetes: a randomized, double-blind, placebo-controlled phase 2 trial Ends 02/14/2016! 💘 treat Size:1 Cookie innofit30-text

Ends 02/14/2016! 💘 treat yourself to some free GLP-1 @remedicalclinic !! #utahmom #utah #glp1

Ongoing research is examining the effects of exercise, including resistance training in combination with GLP-1 RA therapy (ClinicalTrials.gov: NCT05786521, NCT04122716)

innofit30-text

Size:1 Cookie

Baseline micronutrient testing before starting, plus ongoing monitoring of nutrient status, is described as part of a sensible safety plan alongside hydration and electrolyte checks